A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A Randomized, Double-blinded, Placebo-controlled, Parallel, Multi-Center Phase II Clinical Study to Evaluate the Efficacy and Safety of HY209 gel for Patients with Atopic Dermatitis
Epistemonikos ID: 40dd1d48ee89c25bd735775a3d62acc905868927
First added on: May 07, 2024